More congressional interest in generic drugs
Executive Summary
Consumer Interests Subcommittee of the House Select Committee on Aging has scheduled a March 1 hearing on the generic scandal. Chaired by Rep. Lloyd (D-Tenn.), the panel hopes to present "an accurate and balanced record" of the safety and efficacy of generics, according to staff. Witnesses are expected to include representatives of FDA and professional and trade associations.
You may also be interested in...
New China COVID Vaccine Arriving But COVAX Pledge May Need A Booster
China’s first domestically-developed recombinant protein vaccine for COVID-19 moves forward in late-stage trials in two countries.
QUOTED. 9 March 2021. Matthew Trerotola.
Splitting Colfax into separate fabrication technology and specialty medical technology businesses will help both sides of the business grow, CEO Matthew Trerotola said recently.
Catchup Capsule: Key APAC Insights You Need To Read
Given its ever-growing role as a critical component of the global biopharma industry, you can’t afford not to be up to speed on Asia. This selection of recent insights from our experienced on-the-ground team will help.
Need a specific report? 1000+ reports available
Buy Reports
Register for our free email digests: